Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype

Not yet recruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 5, 2025

Study Completion Date

December 5, 2025

Conditions
Healthy
Interventions
OTHER

Cosmetic product RV2666C LA2984

The product is applied, according to randomization, on an area located on the anterior side of the forearm, following the laser YAG act, once a day and under occlusion from Day 1 to Day 3 included. Then it is applied twice a day in an open way from Day 4 until Day 18 included.

Trial Locations (1)

31000

Skin Research Center, Toulouse

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT07166484 - Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin Phototype | Biotech Hunter | Biotech Hunter